Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PiQo4™ the First 4-Wavelength Picosecond Laser Receives FDA Clearance
  • USA - English


News provided by

Zarin Medical, LLC

Sep 16, 2015, 16:40 ET

Share this article

Share toX

Share this article

Share toX

Before-and-After photos with PiQo4
Before-and-After photos with PiQo4
Youtube
Youtube

After 10 years in laser tattoo removal, I'm excited to own the first PiQo4™ in the USA. The unique 4-wavelength picosecond laser offers the highest power, allowing it to be more effective than other lasers. -- Milan Shah, MD (Beautologie)”.

Post this

(PRWEB) September 16, 2015 -- Zarin Medical™ is proud to introduce the first picosecond laser with FOUR wavelengths (specifically, the 1064nm, 532nm, 650nm, and 585nm) to receive FDA clearance. The PiQo4™ system is capable of treating more tattoo inks than any other picosecond laser and users of the previous version already report results with 40% fewer treatments. The PiQo4 has triple the peak power and significantly shorter pulses so investigators anticipate even better results. The system treats all tattoo colors, traumatic tattoos, and amateur tattoos, pigmented lesions such as nevi, lentigines, café-au-lait birthmarks, melasma, and seborrheic keratosis.

The innovative system, designed and manufactured by Focus Medical, offers the highest energy with up to 2000 millijoules in a single pulse. The beam profile is engineered for greater homogeneity to permit industry-leading spot sizes up to 15mm in diameter for enhanced speed and greater depth. The PiQo4 includes a Q-Switch mode, providing more options for picosecond and nanosecond pulse durations than any other picosecond laser.

Nowadays, tattoos include a wide array of colors. Removing them was difficult since most lasers have only one or two wavelengths which target only certain ink colors. The PiQo4 is the one laser that greatly increases the likelihood of reducing/removing tattoos since studies indicate that nine of the most common tattoo colors are highly absorbed by wavelengths that are found in the PiQo4 laser.
1. Black is the most common tattoo color and is highly absorbed by the 1064nm wavelength.
2. Red, the second most-common ink, is highly absorbed by the 532nm wavelength.
3. The third most common ink color is green, which is highly absorbed by the 650nm wavelength.
4. Other colors (such as blues and purples) are highly absorbed by the 585nm wavelength.

The PiQo4 laser also is highly absorbed by dark and light greens, royal and light blue, yellow and pink inks. By contrast, those studies show that laser systems with one wavelength (such as 532nm or 755nm) or systems with two wavelengths (such as 1064nm plus 532nm) are highly absorbed by only four of the most common inks. Additionally, 755nm systems are limited to lighter skin types, whereas the PiQo4’s 1064nm is safer on both darker and lighter skin types.

John Lee, CEO of Focus Medical, reports, “This robust platform has been widely used in Asia for years. Therefore, our company is confident in the system’s reliability and durability.” To introduce the PiQo4 laser to the USA, new systems sold in 2015 include up to an industry-leading three-year warranty. Limitations apply; contact Zarin Medical for details about this introductory offer.

+ + +

About Zarin Medical, LLC
Zarin Medical, LLC is the exclusive distributor of the PiQo4 system in North America (including the USA, Canada, and U.S. territories). Zarin offers best-in-class devices from around the world because they are not limited to a single manufacturer. For more information, please visit http://www.ZarinMedical.com or call toll-free to (844) 927-4600.

About Focus Medical, LLC
Focus Medical (Bethel, CT) has developed a line of aesthetic lasers and light-based devices under the NaturaLase and NaturaLight brands. Focus Medical’s engineering and technology emphasis has produced systems that lead the industry with superior performance, higher energies, and better ease of use.

= = = = =

References:
1. Beute, Miller, Timko and Ross, Dermatol. Surg. 2008; 34:508 – 516.
2. Hædersdal, Bech-Thomsen and Wulf, Arch. Dermatol. 1996; 132: 403-407.
3. Bencini, et al. Arch. Dermatology. 2012; E1-E7.
4. No tattoo lasers are highly absorbed by white inks.

Zarin and Zarin Medical are trademarks of Zarin Medical, LLC.    PiQo4 is a trademark of Focus Medical, LLC.

© 2015, Zarin Medical, LLC. All rights reserved.

Lee Pannell, Zarin Medical, LLC, http://www.zarinmedical.com, +1 8449274600 Ext: 0, [email protected]

Modal title

Downloadable press release of PiQo4 (4-wavelength picosecond laser)
View PDF
Downloadable press release of PiQo4 (4-wavelength picosecond laser)
PiQo4 before-and-after photos (downloadable)
View PDF
PiQo4 before-and-after photos (downloadable)
Downloadable press release of PiQo4 (4-wavelength picosecond laser) PiQo4 before-and-after photos (downloadable)

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.